UK workplaces increasingly rely on drug and alcohol testing to maintain safety, protect staff wellbeing and reduce operational risk. Occasionally, results may highlight the substance DXM, which prompts a common question: what exactly is DXM and should employers be concerned?
DXM stands for Dextromethorphan, a widely used cough suppressant found in many over-the-counter cold and flu medicines. Although legal and safe when used appropriately, DXM can be misused at high doses for its psychoactive effects, impacting judgement, coordination and workplace performance.
This guide explains why DXM may appear on a drug test, the risks associated with its misuse and the important considerations for employers implementing testing programmes.
What employers and schools need to know about Dextromethorphan (DXM)
Dextromethorphan (DXM for short) and known as DEX in slang use in the UK, is included in numerous easily accessible and popular cough and cold preparations available in the UK over the counter. While therapeutic use is not an issue, the substance can cause dissociation and impaired motor function when consumed to excess.
Misuse trends include recreational consumption of DXM-containing syrups mixed with soft drinks, a behaviour sometimes referred to as “lean” use. This presents a risk in any workplace, especially those where concentration, quick reactions and safe machinery operation are essential.
During the 1980s and 1990s, over-the-counter cough medicines containing DXM were regularly misused by medical students and other young adults seeking psychoactive effects. While therapeutic doses are safe, excessive use can cause dissociation, hallucinations, and impaired judgement. The risks are significantly increased when DXM is combined with alcohol, as this potentiation can amplify sedation, reduce coordination, and elevate the likelihood of accidents or dangerous behaviours. For employers, this underscores the importance of robust workplace drug-testing policies—even for substances legally available over the counter—because impairment can have serious safety implications.
How common is misuse of Dextromethorphan ?
The misuse of dextromethorphan (DXM) in the UK is a growing concern, particularly among adolescents and young adults. While precise national statistics are limited, various studies and reports indicate a notable prevalence of DXM misuse.
A systematic review highlighted that DXM was the most reported misused over-the-counter drug, with numerous case reports and studies documenting its abuse. Users often consume DXM-containing cough syrups in high doses to achieve dissociative and hallucinogenic effects, sometimes combining it with other substances like alcohol to potentiate its effects.
In the United States, a significant number of adolescents have reported lifetime misuse of over-the-counter medications, including those containing DXM. This trend underscores the potential for similar patterns in the UK, especially given the accessibility of these products.
Furthermore, a study involving adult members of an online DXM community found that many individuals began using DXM at a young age and often combined it with other substances to enhance its effects. This behaviour raises concerns about the broader implications of DXM misuse and its potential to serve as a gateway to other substance abuses.
Given these findings, it's crucial for employers to be aware of the risks associated with DXM misuse, as it can impair judgment, coordination, and overall workplace safety. Implementing comprehensive drug testing policies and educating staff about the potential dangers of misusing over-the-counter medications can help mitigate these risks.
DXM awareness in schools
Although DXM is a legally available cough suppressant, schools should be aware that misuse can occur among teenagers seeking its psychoactive effects. Even a single episode of high-dose consumption can cause dizziness, disorientation, impaired coordination, and in combination with alcohol, serious health risks. Educators and school administrators can play a crucial role in prevention by including DXM in substance-awareness programmes, monitoring access to cough medicines, and providing clear guidance on the dangers of misuse. Early education and awareness help protect students and maintain a safe learning environment.
How DXM Misuse Can Affect Workplace Safety
DXM misuse can lead to:
- Impaired decision-making and delayed reaction times
- Disorientation and difficulty focusing on tasks
- Increased heart rate and high blood pressure
- Risk of accidents due to poor coordination
- Possible long-term mental health concerns including anxiety and mood changes
The combination of DXM with alcohol or other medicines, including some antidepressants or paracetamol-containing products, significantly increases harm.
For employers this means a clear potential for reduced performance, elevated safety risks and increased absenteeism, particularly in safety-critical roles such as construction, transport, healthcare and manufacturing.
Why Test for DXM?
Testing for DXM can be a crucial part of a robust workplace drug-testing policy. Relevant scenarios include:
Pre-employment screening
Helps ensure candidates are fit for roles involving responsibility or safety risks.
For-cause or post-incident testing
If an individual demonstrates signs of impairment or when investigating workplace accidents.
Random drug testing programmes
Supports a proactive safety culture, ensuring compliance with company policies and legislative requirements.
DXM misuse can otherwise remain undetected due to the legal nature of the medicine. Testing provides clarity and supports employers in meeting their legal Duty of Care.
How DXM Drug Tests Work
DXM is detectable in urine for approximately 1-3 days after misuse. Workplace testing typically uses immunoassay screening, which may detect both DXM and its primary metabolite, DXO.
As with any screening test, false positives can occur, sometimes triggered by legally used cold and allergy medications. Any non-negative result should be verified by a laboratory confirmation test, such as GC-MS, before employment decisions are made in order to comply with UK best practice and ACAS guidance.
Employers should ensure:
- Testing methods and laboratories are UKAS accredited
- Policies are clearly communicated to staff
- Chain-of-custody procedures are followed fully
- Confidentiality is maintained at every stage
Promoting a Supportive Safety Culture
Identifying DXM misuse is not about punishment. The goal is to create a safer environment and provide support where needed. Early detection enables employers to intervene, signpost appropriate help and take proportionate action under company policy.
At UK Drug Testing, we supply workplace-appropriate DXM test kits designed to deliver reliable screening results and help employers take informed, responsible decisions that protect both their people and their operations.
⚠️ Ensure Workplace Safety with DXM Detection
Dextromethorphan (DXM) misuse can impair judgment and coordination, posing serious risks in safety-critical environments. Our ALLTEST Ultra Dextromethorphan Urine Drug Test Strips (DXM20) offer a reliable solution for detecting DXM use, ensuring your team remains fit for duty.
🔍 Product Features:
- High Sensitivity: Detects DXM at 100ng/mL, identifying recent misuse.
- Rapid Results: Provides clear outcomes in just 3–5 minutes.
- Extended Detection Window: Identifies use within up to 48 hours.
- Individually Foil-Sealed: Ensures maximum reliability and shelf-life.
- Accuracy Rate: 99.9% for trustworthy results.
Protect your workplace and uphold safety standards by incorporating DXM testing into your drug screening program.
Order DXM urine drug test strips in bulk now
Order DXM urine drug tests strips in small packs
For bulk orders or tailored drug testing solutions specific to your workplace demographic, please contact our support team via chat during office hours or via email at support@ukdrugtesting.co.uk or call 01263 731 168 during office hours.